Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | SLC13A5 | Q86YT5 | 9/20 | 0.46 |
| ▸ | ACLY | P53396 | 3/20 | 0.41 |
| ▸ | CPT2 | P23786 | 1/20 | 0.41 |
| ▸ | HMGCR | P04035 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18283303 | 1.00 | ALDH1A1 (0.67) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL2636987 | 0.84 | ALDH1A1 (0.83) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL426935 | 0.84 | ALDH1A1 (0.83) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL9299044 | 0.84 | ALDH1A1 (0.94) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL227914 | 0.84 | ALDH1A1 (0.94) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL664207 | 0.84 | ALDH1A1 (0.94) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL29629071 | 0.84 | ALDH1A1 (0.94) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL28100234 | 0.82 | ALDH1A1 (0.79) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL5173630 | 0.81 | ALDH1A1 (0.88) | ALDH1A1SLC13A5ACLYCPT2HMGCR | |
| Citric Acid SCHEMBL5425793 | 0.81 | ALDH1A1 (0.88) | ALDH1A1SLC13A5ACLYCPT2HMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2581081-A2 | Treatment of viral infections by modulation of host cell metabolic pathways | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2013-04-17 | — | — | EP | disclosed |
| EP-2572712-A2 | Treatment of viral infections by modulation of host cell metabolic pathways | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2013-03-27 | — | — | EP | disclosed |